Breast cancer is one of the most abominable killers in the US today. From 15 to 30 percent of the 44,000 women diagnosed with breast cancer each year do not survive. There is a great need for non-invasive cancer diagnostics and treatment techniques, especially for breast cancer. Most current technologies are invasive and present a host of problems, such as secondary cancer exposure, long diagnostic/treatment time, low resolution, which are aggravated by human errors and misinterpretation of results.

Micro LDRI™ is a breakthrough medical technology invented, developed and patented by our company. Its main application is safer diagnostics and treatment of patients with soft tissue tumors during early stages of tumor development, where existing methods do not produce adequate results.

This technology allows doctors to work with three-dimensional images, permitting physicians to scan soft tissue organs with a degree of accuracy unattainable with traditional techniques.

Micro LDRI™ is a hypersensitive receptor technology coupled with low-radiation radioactive tracers. It allows scanning of soft tissues with less than one-tenth the radiation dosage required by traditional diagnostic methods. This will permit more frequent and therefore more effective preventive checks for tumors with a simultaneous thousand-fold reduction in risk typical of higher radiation exposure associated with conventional methods.

Using our hardware and software, data obtained by detectors is fed into a fast microcomputer. The software allows full rotation of the developed 3D images. The computer enhances the latent image in much the same manner that images from the Hubble Space Telescope are enhanced to provide sharper, clearer images of the object in view. Preliminary tests of this technology indicate that the accuracy of the data images produced could surpass existing MRI and CT scanning technologies by as much as 20 to 30 times in detail and accuracy, and provide image development in real time, significantly reducing diagnostics errors.

Salitech technology combines a precision, real-time imaging system with low dosage radiation. The imaging system provides real-time feedback for precision control of treatment procedures, and real time 3-D images reconstruction.

This improvement in accuracy will allow for safe diagnostics and treatment of tumors less than 0.5mm in diameter, whereas CT and MRI technology can only detect much larger tumors. For many patients, diagnosis at this late stage offers only a prognosis of how many years they have before they pass away. Diagnosing a tumor as small as 0.5mm means that a cancer may be diagnosed and treated from 7 to 12 years sooner. This increase in successful treatment of soft tissue tumors offers the opportunity for elimination of the cancer before it can metastasize.